Bookmark

Add to MyYahoo RSS

Novartis News

News on Novartis (Ticker: NVS) continually updated from thousands of sources around the net.

26 min ago | Investor's Business Daily

Biogen Trounces Q2 Estimates As Tecfidera Outperforms

Biogen's Q2 earnings rose 52% over the year-earlier quarter to $3.49 a share, topping analysts' consensus by 66 cents.

Comment?

Related Topix: Biotech, Biogen Idec

Fri Jul 18, 2014

Benzinga

5 New Medical Technologies For Diabetics

News of the recent partnership between European drugmaker Novartis and Google to develop a contact lens designed to monitor blood sugar levels in diabetics has drawn attention to several other new diabetes treatment developments.

Comment?

Related Topix: Biotech, Google, Startups, ITA Software, Enterprise Mobile, Widevine Technologies, AdMob

Benzinga

Novartis Joins Google To Develop Contacts For Diabetics

Development of devices and mobile applications in the health care sector has exploded of late.

Comment?

Related Topix: Biotech, Google, Startups, Enterprise Mobile, WebMD, Widevine Technologies, AdMob

Thu Jul 17, 2014

GlobalNews

Five signs of diabetes people should be aware of

The 2.5 million Canadians with diabetes may be able to track their sugar levels in real-time due to a partnership between Google and the Swiss pharmaceutical company, Novartis.

Comment?

Related Topix: Medicine, Health, Diabetes, Biotech

TheStreet.com

Why Novartis (NVS) Stock Is Down Today

The worlds largest drug maker reported a year over year quarterly revenue increase of 1% to $14.64 billion, below analysts $14.83 billion forecast.

Comment?

Related Topix: Biotech, Warren Buffett, Financial Markets

Seeking Alpha

Novartis' (NVS) CEO Joe Jimenez on Q2 2014 Results - Earnings Call Transcript

Good morning and good afternoon and welcome to the Novartis Q2 Half Year 2014 Results Conference Call and Live Audio Webcast.

Comment?

Related Topix: Biotech, CPU, Science / Technology

Insider Monkey

Foreign Companies News: Rio Tinto plc (ADR) (RIO), Novartis AG (ADR)...

Rio Tinto plc , the world's second-biggest mining company, is now seeing iron ore trading close to $100 per metric ton.

Comment?

Related Topix: Rio Tinto, Companhia Vale do Rio Doce, Mining, Biotech

Star-Telegram.com

Alcona s parent, Novartis, cites momentum in 3 percent profit rise

GENEVA Novartis, the Swiss pharmaceutical company that owns Fort Worth-based Alcon, posted a 3 percent rise in second-quarter profits today, reflecting what it described as solid growth and an increased focus on core products.

Comment?

Related Topix: Biotech, Fort Worth, TX

AmericanBankingNews.com

Novartis AG (NVS) Announces Quarterly Results

Novartis AG released its earnings data on Thursday. The company reported $1.36 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $1.36, American Banking & Market News reports.

Comment?

Related Topix: The Visionaire Group, Solve, Biotech, Novartis AG, Novartis, Medicine, VISH, Medical Equipment, Healthcare Industry

The Standard

Drug maker Novartis sees profits surge

Swiss pharmaceutical giant Novartis said Thursday its net profits for the first half had shot up by 13 percent and stuck by its forecast of continued sales growth across the year.

Comment?

Related Topix: Biotech

KAUZ

Novartis cites momentum in 3 percent profit rise

The Palestinian-American teen who relatives allege was beaten by Israeli authorities earlier this month has arrived home in Florida.

Comment?

Related Topix: Biotech, Florida, Piracy News, Weather, Natural Disasters, Wildfire, Fire

KTVN Reno

Novartis cites momentum in 3 percent profit rise

A state of emergency has been declared in 20 Eastern Washington counties because of multiple wildfires and scorching hot temperatures coupled with high winds on Wednesday.

Comment?

Related Topix: Biotech, Weather, Natural Disasters, Wildfire, Fire, Florida

Wed Jul 16, 2014

Seeking Alpha

Why Pfizer Could Beat This Sector Peer

We pitch two companies from the pharmaceuticals sector, Pfizer and Novartis, against one another in the latest instalment of our Head-To-Head series.

Comment?

Related Topix: Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Novartis

Local Tech Wire

Yahoo earnings fall; N.C. Solar Center's new name; Novartis-Google...

Yahoo Inc. said Tuesday that its second-quarter earnings and revenue declined, as the company struggled again with display advertising sales.

Comment?

Related Topix: Startups, Yahoo!, Yahoo, iPhone and iPad App, Biotech, WebMD, Emerging Technology, Search Engines, Internet, Science / Technology

The Independent

Google and Novartis to develop contact lens for diabetics

It is hoped that the new lenses will not only improve eyesight for regular users but also monitor insulin levels among people with diabetes The technology giant Google has teamed up with the Swiss pharmaceutical company Novartis to develop the next generation of contact lenses.

Comment?

Related Topix: Google, Startups, Emerging Technology, Search Engines, Biotech, Medicine, Insulin (generic), Humulin, Novolin, Diabetes, Health, Food and Drug Administration

Tue Jul 15, 2014

Seeking Alpha

Novartis to test Alzheimer's drug candidates in asymptomatic patients

Novartis plans to test two experimental Alzheimer's drugs on patients with a genetic risk of developing dementia caused by the buildup of amyloid protein.

Comment?

Related Topix: Biotech, Novartis, Medicine, Healthcare Industry, Genetics

Mon Jul 14, 2014

AndhraNews

Novartis to license Google 'smart lens' technology

Novartis International AG /Novartis to license Google "smart lens" technology. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Comment?

Related Topix: Google, Startups, Emerging Technology, Search Engines, Biotech, Sergey Brin

Wed Jul 09, 2014

CSRwire.com

Novartis Releases 2013 Corporate Responsibility Performance Report...

Novartis has published a Corporate Responsibility Performance Report for 2013. The report reflects the best-in-class reporting standard, the Global Reporting Initiative's G4 guidelines, one year in advance of required implementation.

Comment?

Related Topix: Biotech

Tue Jul 08, 2014

Seeking Alpha

GlaxoSmithKline Is Moving Forward After Woeful Performance

GSK to swap key assets with Novartis, of which its Oncology division will be sold for a lucrative $16 billion.

Comment?

Related Topix: Biotech, GlaxoSmithKline, Medicine, Healthcare Industry

Seeking Alpha

Jakavi approval triggers milestone payment

The approval of Jakavi for the treatment of myelofibrosis by the Japanese Ministry of Health, Labor and Welfare triggers a $25M milestone payment to Incyte Corp. from collaboration partner Novartis .

Comment?

Related Topix: Incyte, Biotech

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••